University Hospital La Fe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from University hospital la fe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In University Hospital La Fe Today - Breaking & Trending Today

Frontline Quizartinib Plus Chemotherapy Shows Curative Potential in FLT3-ITD Wild-Type AML

The addition of quizartinib to standard induction and consolidation chemotherapy with idarubicin plus cytarabine followed by maintenance therapy led to an improvement in event-free survival compared with placebo plus chemotherapy in patients with FLT3-ITD wild-type acute myeloid leukemia. ....

Pau Montesinos , University Hospital La Fe , European Leukemianet , Addition Of Quizartinib To Standard Induction And Consolidation Chemotherapy , Patients With Flt3 Itd Wild Type Acute Myeloid Leukemia , Quiwi Trial ,

Dr Montesinos on Quizartinib Plus Chemotherapy in Newly Diagnosed FLT3-ITD Wild-Type AML

Dr Montesinos on Quizartinib Plus Chemotherapy in Newly Diagnosed FLT3-ITD Wild-Type AML
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Pau Montesinos , University Hospital La Fe ,

Quizartinib Plus Chemotherapy Improves EFS, RFS in Newly Diagnosed FLT3-ITD–Negative AML

Pau Montesinos, MD, PhD, discusses the preliminary results of the QUIWI trial, expands on the potential implications for the use of quizartinib plus chemotherapy in newly diagnosed patients with FLT3-ITD–negative acute myeloid leukemia, and details the next steps for this study and future research. ....

Pau Montesinos , University Hospital La Fe , Quizartinib Plus Standard Induction And Consolidation 3 7 Chemotherapy Followed By Maintenance , Adult Patients With Newly Diagnosed Flt3 Itd Negative Acute Myeloid Leukemia , Quiwi Trial ,